<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8499234</identifier>
<setSpec>0214-1221</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Martínez, M J</dc:author>
<dc:author>López Pereira, P</dc:author>
<dc:author>Muguerza, R</dc:author>
<dc:author>Jaureguizar, E</dc:author>
<dc:description xml:lang="en">Intravesical oxybutynin chloride was administered to 12 children with neurogenic bladder and incontinence who had unacceptable side effects. Urodynamic studies showed hyperreflexia was eliminated or improvement in 100% of them and low compliance was improved (88%), with a mean increase in bladder volume to 123% and a mean decrease of filling pressure to 24 cm H2O. Six patients became completely dry (50%), 4 continent period was increased and 2 did not improve. No systemic effects were observed.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1993 Jan </dc:date>
<dc:title xml:lang="es">Tratamiento tópico con cloruro de oxibutinina en la incontinencia de causa neurógena.</dc:title>
<dc:title xml:lang="en">[Topical treatment with oxybutynin chloride in neurogenic incontinence].</dc:title>
<dc:publisher>Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica</dc:publisher>
</metadata>
</record>
</pubmed-document>
